Effects of Cocoa on Gastrointestinal Function
NCT03022955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2018-02-12
Summary
This is a randomized, controlled, 2x2 cross-over study to assess the effects of cocoa solids on gastrointestinal transit, post-prandial sensation and well-being. Additionally functional brain imaging will be applied to identify regions of brain that are activated or inactivated by cocoa ingestion. Healthy subjects will be recruited and randomized to receive either dark chocolate (70% cocoa solids) or white chocolate (0% cocoa solids) in addition to their normal diet in randomized order. Reference standard methodology will be applied to measure gastric emptying, oro-caecal and colonic transit time. Dark and white chocolate (100g, \~500kcal, \~50% fat) will be consumed with radio-opaque markers on three consecutive days. On the third day chocolate ingestion will be followed by measurements of postprandial brain activity using FDG-Positron Emission Tomography. Additionally colonic transit will be assessed based on the number and distribution of radio-opaque markers in the colon. On the fourth day gastric emptying and oro-caecal transit time will be assessed by scintigraphy after ingestion of a dark or white chocolate mousse test meal (both 150g, \~500kcal, \~50% fat). During both interventional studies pre- and post-prandial satiety and dyspeptic symptoms, well-being and mood will be recorded. Additionally, validated questionnaires will assess digestive comfort and well-bring at the end of each study day. These results will deliver comprehensive information about the effects of cocoa on gastrointestinal transit and sensation.
Conditions
- Gastrointestinal and Digestive Disorder
Interventions
- DIETARY_SUPPLEMENT
-
Dark chocolate bar
Dark chocolate bar (70% cocoa solids (\~500kcal, \~50% fat)), 100g / day for 3 days to assess postprandial brain activity and colonic transit by FDG-PET.
- DIETARY_SUPPLEMENT
-
Dark chocolate mousse
Dark chocolate mousse (150g, \~500kcal, \~50% fat) to assess gastric emptying and oro-caecal transit time by scintigraphy.
- DIETARY_SUPPLEMENT
-
White chocolate bar
White chocolate bar (0% cocoa solids (\~500kcal, 50% fat)), 100g / day for 3 days to assess postprandial brain activity and colonic transit by FDG-PET.
- DIETARY_SUPPLEMENT
-
White chocolate mousse
White chocolate mousse (150g, \~500kcal, \~50% fat) to assess gastric emptying and oro-caecal transit time by scintigraphy.
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Mark Fox, Prof. Dr. · St. Claraspital Basel, Abdominal Center: Gastroenterology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Effects of Butyrate on Colonic Health of Patients With Diarrhoea Predominant IBS and UC in Remission
NCT00696098 ·Status: COMPLETED ·Phase: NA
-
The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level
NCT02980406 ·Status: COMPLETED ·Phase: NA
-
Effect of FODMAPs on Mucosal Inflammation in IBS Patients
NCT03221790 ·Status: UNKNOWN ·Phase: NA
-
Human Milk Oligosaccharides (HMOs) for Irritable Bowel Syndrome (IBS)
NCT05205785 ·Status: TERMINATED ·Phase: NA
-
Change in Permeability of the Small Intestine After Treatment With Gluten
NCT02098057 ·Status: COMPLETED ·Phase: NA
-
Effects of Fasting and Hydro Colon Therapy Plus Probiotics on GI Microbiota in Intolerances and Irritable Bowel Syndrome
NCT02372201 ·Status: COMPLETED ·Phase: NA
-
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808 ·Status: COMPLETED ·Phase: NA
-
Gluten-free Diet in Irritable Bowel Syndrome
NCT02528929 ·Status: COMPLETED ·Phase: NA
-
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
NCT01339117 ·Status: COMPLETED ·Phase: NA
-
Intracolonic FODMAP Infusion in Healthy Volunteers
NCT06488534 ·Status: COMPLETED ·Phase: NA
-
Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome
NCT01624610 ·Status: COMPLETED ·Phase: NA
-
Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS Patients
NCT03550742 ·Status: COMPLETED ·Phase: NA
-
Cheno Effect on Transit in Health and IBS-C
NCT00912301 ·Status: COMPLETED ·Phase: PHASE2
-
Skydiving as a Model of Psychological Stress and Its Effect on Intestinal Barrier Function
NCT03644979 ·Status: COMPLETED ·Phase: NA
-
Effect of a Low- Fermentable-Oligo-Di- Monosaccharides and Polyols Diet Group Intervention on IBS Symptoms and Fatigue
NCT05124262 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
NCT03270085 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers
NCT01927900 ·Status: COMPLETED ·Phase: NA
-
A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers
NCT02727283 ·Status: COMPLETED ·Phase: PHASE1
-
Endomicroscopy, IBS and Food Intolerance
NCT01692613 ·Status: COMPLETED
-
Confocal Laser Endomicroscopy to Determine Influence of Food Antigens on Mucosal Integrity
NCT05056610 ·Status: COMPLETED ·Phase: NA
-
Effects of Faecal Microbiota Transplantation in Patients With IBS
NCT03822299 ·Status: COMPLETED ·Phase: NA
-
Brain-Gut-Microbiota Interaction in IBS
NCT04296552 ·Status: UNKNOWN ·Phase: NA
-
ConfocAl endomicroSCopy bAsed Diet Trial in IBS
NCT05097872 ·Status: RECRUITING ·Phase: NA
-
Internet-delivered Exposure-based Cognitive Behavior Therapy for Irritable Bowel Syndrome - a Cohort Effectiveness Study
NCT05328245 ·Status: COMPLETED
-
Diet Reintroduction Study in Irritable Bowel Syndrome
NCT03052439 ·Status: COMPLETED ·Phase: NA